Application 212727
- Type
- ANDA
- Sponsor
- METHOD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 1MG BASE | No | No |
| 002 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 2MG BASE | No | No |
| 003 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 4MG BASE | No | No |
| 004 | DOXAZOSIN MESYLATE | DOXAZOSIN MESYLATE | TABLET;ORAL | EQ 8MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58657-820 | Doxazosin | Doxazosin | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-820 | Doxazosin | Doxazosin | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-821 | Doxazosin | Doxazosin | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-821 | Doxazosin | Doxazosin | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-822 | Doxazosin | Doxazosin | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-822 | Doxazosin | Doxazosin | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-823 | Doxazosin | Doxazosin | Method Pharmaceuticals, LLC | ANDA | Current |
| 58657-823 | Doxazosin | Doxazosin | Method Pharmaceuticals, LLC | ANDA | Current |